Its role Owner
Crysalis Biosciences Inc. is a privately held U.S. biomanufacturing company specializing in the repurposing of dormant industrial infrastructure into advanced biorefineries for low-carbon fuels and biochemicals.
Headquartered at its primary facility in Sauget, Illinois, the company operates the Monarch project at a former ethanol plant, converting it to produce sustainable aviation fuel (SAF) through ethanol-to-jet processes alongside low-carbon pharmaceutical-grade solvents. It also generates co-products such as protein-rich syrups, wet and dried distillers grains for animal feed, and biogenic CO2 captured from renewable sources.
Founded in 2022, Crysalis processes sustainable biomass feedstocks via microbial fermentation and proprietary refinement technologies, including those licensed from the National Renewable Energy Laboratory. The company maintains additional locations or research capabilities in Columbus, Georgia, and Louisville, Colorado, and is led by CEO Sanket Gandhi.
Operating in the sustainable fuels and bio-based chemicals industry, Crysalis focuses on reducing carbon intensity in aviation and industrial sectors while revitalizing U.S. manufacturing assets. It has received Illinois state incentives for its SAF development and collaborates on scaling domestic biomanufacturing technologies.
Also known as Crysalis Biosciences, Inc..
chemXplore tracks 1 project involving Crysalis Biosciences, of which one is active.
active all projects
